However, they reported some suggestive evidence of an inverse association between adiponectin and advanced prostate cancer (meta relative risk 0.81 (95%CI 0.61–1.08) comparing the highest subset of adiponectin). The gene discussed is ADIPOQ; the disease is prostate carcinoma.